Motixafortide and G-CSF To Mobilize Hematopoietic Stem Cells for Autologous Transplantation in Multiple Myeloma: A Randomized Phase 3 Trial

This Phase III study was designed to compare the safety and efficacy of motixafortide + granulocyte colony-stimulating factor (G-CSF) versus placebo + G-CSF in patients with multiple myeloma undergoing hematopoietic stem progenitor cell mobilization before autologous hematopoietic stem cell transplantation.